Timothy Rolph - 25 Nov 2025 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Chief Scientific Officer
Signature
/s/ Jonathan Young, Attorney-in-Fact
Issuer symbol
AKRO
Transactions as of
25 Nov 2025
Net transactions value
+$624,087
Form type
4
Filing time
28 Nov 2025, 06:03:26 UTC
Previous filing
19 Nov 2025
Next filing
09 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rolph Timothy Chief Scientific Officer 601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO /s/ Jonathan Young, Attorney-in-Fact 28 Nov 2025 0001779479

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Options Exercise $99,990 +3,527 +2.7% $28.35 132,998 25 Nov 2025 Direct
transaction AKRO Common Stock Options Exercise $274,059 +43,064 +32% $6.36 176,062 25 Nov 2025 Direct
transaction AKRO Common Stock Options Exercise $90,350 +4,284 +2.4% $21.09 180,346 25 Nov 2025 Direct
transaction AKRO Common Stock Options Exercise $1,720 +2,796 +1.6% $0.6150 183,142 25 Nov 2025 Direct
transaction AKRO Common Stock Options Exercise $57,975 +94,268 +51% $0.6150 277,410 25 Nov 2025 Direct
transaction AKRO Common Stock Options Exercise $99,993 +4,739 +1.7% $21.10 282,149 25 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -2,796 -100% $0.000000 0 25 Nov 2025 Common Stock 2,796 $0.6150 Direct F1
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -94,268 -100% $0.000000 0 25 Nov 2025 Common Stock 94,268 $0.6150 Direct F1
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -43,064 -100% $0.000000 0 25 Nov 2025 Common Stock 43,064 $6.36 Direct F1
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -4,284 -100% $0.000000 0 25 Nov 2025 Common Stock 4,284 $21.09 Direct F1
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -3,527 -100% $0.000000 0 25 Nov 2025 Common Stock 3,527 $28.35 Direct F1
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -4,739 -100% $0.000000 0 25 Nov 2025 Common Stock 4,739 $21.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are vested and currently exercisable.